Showing results (351-360 of 370) with videos related to
Sort By:
Pageof 37
The Journal of Nutrition, Health & Aging|March 1, 2017
Factors Affecting Functional Impairment among Elderly Germans - Results of a Longitudinal StudyA Hajek, T Luck, C Brettschneider, et al.Medrxiv : the Preprint Server for Health Sciences|November 1, 2024
An Online Application to Explain Community Immunity with Personalized Avatars: A Randomized Controlled TrialHina Hakim, Julie A Bettinger, Christine T Chambers, et al.The Journal of Infectious Diseases|March 27, 2024
A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US AdultsCarol M Kao, Christina A Rostad, Lauren E Nolan, et al.Journal of Medical Internet Research|October 30, 2020
A Web Application About Herd Immunity Using Personalized Avatars: Development StudyHina Hakim, Julie A Bettinger, Christine T Chambers, et al.Molecular Neurobiology|May 27, 2023
The E3 Ubiquitin Ligase SCF Cyclin F Promotes Sequestosome-1/p62 Insolubility and Foci Formation and is Dysregulated in ALS and FTD PathogenesisJennilee M Davidson, Sharlynn S L Wu, Stephanie L Rayner, et al.The Lancet. Infectious Diseases|June 30, 2026
Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trialNadine Rouphael, Shahida Baqar, Michelle Dickey, et al.Vaccine|October 17, 2024
Safety and immunogenicity of a ChAd155-vectored rabies vaccine compared with inactivated, purified chick embryo cell rabies vaccine in healthy adultsVarun K Phadke, Daniel J Gromer, Paulina A Rebolledo, et al.Nature Biotechnology|August 28, 2012
Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigensFrank Wegmann, Kate H Gartlan, Ali M Harandi, et al.Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus AntibodiesLakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.Science Immunology|June 13, 2020
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patientsLakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.Pageof 37